2 AI Stocks to Buy in 2026, and 1 to Avoid
The Motley Fool • • business
Key Points:
- Meta Platforms is heavily investing in AI, driving strong revenue and earnings growth through enhanced user engagement and targeted advertising, despite some investor concerns about its AI infrastructure costs.
- Apple is benefiting from AI integration in its latest iPhone 17, leading to robust revenue growth and a projected double-digit increase, with AI expected to enhance its devices and expand its large installed base.
- Recursion Pharmaceuticals uses AI to accelerate drug discovery and reduce R&D costs, but remains a high-risk investment due to lack of market products, no phase 3 candidates, and competition from larger firms in AI drug development.
- Meta Platforms and Apple are considered attractive AI stock investments for 2026 due to their established ecosystems and monetization opportunities, while Recursion Pharmaceuticals presents significant
